Author Biography
James Dooley, Editor-in-Chief, worked with Professor DameSheila Sherlock on this book for three editions before her death inDecember 2001. He is a Consultant Hepatologist at the Royal FreeHospital, London. Andrew Burroughs is a Consultant Physician andHepatologist at the Royal Free Hospital, Liver Transplantation andHepato-biliary Medicine Unit. He qualified in Liverpool with a MBChB Honours in 1976, gained his MRCP in 1978 and FRCP in 1991. Heis a Fellow of the European Board of Gastroenterology. He has beenScientific Secretary of the European Association for the Study ofthe Liver 1997-1999. He continues his association with EASL asadministrative secretary until 2001. He is a council member of theUnited European Gastroenterology Federation until 2002, and acouncil member of the International Association for the Study ofthe Liver. He is a member of the MRC advisory board in the UK, from1997 onwards. He was a member of Council of the British Society ofGastroenterology from 1992 to 1995. Andrew Burroughs main researchinterests are portal hypertension, variceal bleeding andcoagulopathy, primary biliary cirrhosis, prognosis in liver diseaseand liver transplantation. He has published over 200 peer-reviewedarticles. Anna Lok is a Professor of Internal Medicine and theDirector of Clinical Hepatology at the University of MichiganMedical Center. Her research focuses on the epidemiology andtreatment of hepatitis B and C viruses. Millions of peopleworldwide are infected and are at risk for hepatitis-associatedcirrhosis and hepatocellular carcinoma. Dr. Lok has made seminalcontributions to our understanding of the natural history ofhepatitis B and the role of hepatitis B virus genotypes andvariants in the outcome of chronic hepatitis B infection. She hasalso made contributions to the treatment of hepatitis-induceddiseases. She is currently testing new antiviral therapies forhepatitis B, developing cost-effective methods for preventingrecurrent hepatitis B infection following liver transplantation,and studying the long-term effects of interferon treatment inpatients with hepatitis C. During her distinguished career, she hasreceived numerous awards for research and teaching. Jenny Heathcote, Toronto Western Hospital, Canada.
